BeiGene, Ltd.

Ownership Transactions Reported by 24 Insiders

Symbol
ONC on Nasdaq, BEIGF on OTC
Location
C/O Mourant Governance Services (Cayman), 94 Solaris Avenue, Camana Bay, Grand Cayman, Cayman Islands

Insiders trading volume in the past year

BeiGene, Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Hhlr Advisors, Ltd. 10%+ Owner $25B -$3.57B -12.5% Dec 2, 2024
Amgen Inc 10%+ Owner $3.42B Sep 10, 2021
John Oyler Chief Executive Officer, Director $2.25B -$83M -3.56% Sep 16, 2025
Baker Bros. Advisors Lp Director $2.14B -$385M -15.3% May 21, 2025
Xiaodong Wang Director, Chair, Scientific Advisory Brd $1.2B -$77.8M -6.07% Sep 9, 2025
Donald W. Glazer Director $565M Jun 5, 2024
Lai Wang Global Head of R&D $394M -$5.6M -1.4% Sep 9, 2025
Xiaobin Wu President and COO $367M -$69.4M -15.9% Aug 13, 2025
Howard Liang CFO & Chief Strategy Officer $323M Jun 28, 2021
Julia Aijun Wang Chief Financial Officer $88.6M Jul 1, 2024
Chan Henry Lee SVP, General Counsel $75.1M -$7.78M -9.39% Sep 10, 2025
Aaron Rosenberg Chief Financial Officer $50.2M -$346K -0.68% Aug 1, 2025
Jane Huang CMO, Hematology $33.2M Dec 14, 2021
Titus B. Ball Principal Accounting Officer $21.6M -$74.5K -0.34% Sep 2, 2025
(Corsee) Sanders Corazon Director $17.1M -$898K -5% Sep 5, 2025
Anthony C. Hooper Director $15.9M May 21, 2025
Thomas Malley Director $15.1M Jun 15, 2023
Margaret Dugan Director $13.9M May 21, 2025
Alessandro Riva Director $13.9M May 21, 2025
Olivier Brandicourt Director $6.69M May 21, 2025
Qingqing Yi Director $6.37M Jun 10, 2025
Shalini Sharp Director $4.69M May 21, 2025
Jingshyh S. su Director $1.62M Jun 16, 2021
Timothy Yung-Cheng Chen Director $1.62M Jun 16, 2021

Recent Insider Transactions by Companies or Individuals for BeiGene, Ltd.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.